The Pharmaceutical Journal
Vol 274 No 7353 p703
11 June 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

Growth factor may help Crohn’s

Severity of Crohn’s disease may be decreased by a haematopoietic growth factor.

Researchers found that administering sargramostim 6µg/kg/day to patients with active Crohn’s disease decreased disease severity and improved the patients’ quality of life (New England Journal of Medicine 2005;352:2193).